Top news of the week: 13.05.2021.
Companies And Industries
CLOSE TO THE EDGE: Exclusive Live Interviews with Biotech Executives from GEN EDGE
In the first live episode of "Close to the Edge" on May 12 GEN Edge welcomes Christian Henry, the CEO of PacBio, for an exclusive interview. We’ll have lots to discuss, including PacBio’s ...
Bobbitt promoted to strategy director role at The Bloc
Antoinette Bobbitt has been promoted to executive vice president, strategy director at independent US creative agency, The Bloc.
Listen: Vaccine riches, patent waivers, & a gene therapy for aging
Moderna and Pfizer are poised to make billions from their Covid-19 vaccines, and we discuss what that portends for both companies.
BioNTech, Fosun Pharma eye 1B doses of COVID-19 vaccine capacity with new China JV
As BioNTech makes inroads with its COVID-19 vaccine in Western countries under a partnership with Pfizer, the German biotech is bringing its work in China to the next level with a joint ...
Former Google CEO Schmidt says AI ‘will have its biggest impact’ in health care
“AI will have its biggest impact in biology and health, because biology is so complicated,” Schmidt said at the STAT Health Tech Summit.
Watch: Former Google CEO Schmidt opens up on health data privacy and the future of tech in medicine
In a wide-ranging and forthcoming interview, former Google CEO Eric Schmidt opened up about a host of issues facing the future of medicine.
Moderna’s founder launches Laronde, promising new ‘Endless RNA’ drug class
Flagship Pioneering, the VC fund run by Moderna’s co-founder Noubar Afeyan has launched a new biotech Laronde, with an ambitious plan to create a new class of drugs based on Endless RNA.
Clinical Catch-Up: May 3-7
It was a busy week for clinical trial news. Here’s a look.